© 2022 BioMarin. All rights reserved.
| Beta | 0.33 |
|---|---|
| Shares Outstanding | 185.0M |
| Average Volume (10 days) | 1.5M |
| Qtrly Dividend (Ann. Yield) | -- (--) |
| Earnings (TTM) | $0.18 |
|---|---|
| Sales (TTM) | $7.45 |
| Book Value (MRQ) | $23.24 |
| Cash Flow (TTM) | $1.53 |
| Cash (MRQ) | $5.74 |
| Current Mean Recommendation | Buy |
|---|
| Strong Buy | 9 | |
|---|---|---|
| Buy | 1 | |
| Hold | 3 | |
| Underperform | 0 | |
| Sell | 0 |
Brian Mueller EVP, Chief Financial Officer | (576) Dispose Jun 29, 2022 |
|---|---|
Jeffrey R. Ajer EVP, Chief Commercial Officer | (7,021) Dispose Jun 3, 2022 |
Jeffrey R. Ajer EVP, Chief Commercial Officer | (1,308) Sell May 26, 2022 |
Mark J. Alles Director | 4,980 Acquire May 24, 2022 |
Maykin Ho Director | 4,980 Acquire May 24, 2022 |